• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOCOMPATIBLES UK LTD THERASPHERE; YTTRIUM-90 GLASS MICROSPHERES, PRODUCT CODE: NAW

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOCOMPATIBLES UK LTD THERASPHERE; YTTRIUM-90 GLASS MICROSPHERES, PRODUCT CODE: NAW Back to Search Results
Model Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Hemorrhage/Bleeding (1888)
Event Date 04/28/2019
Event Type  Injury  
Manufacturer Narrative
Btg medical assessment: the patient had pre-existing portal hyper tension and was taking anticoagulation.It is possible that therasphere treatment had transitory increased portal hypertension leading to pre-existing variceal bleeding.Anticoagulation treatment might have favoured this event.Melena: grade 3; serious - led to hospitalisation; anticipated; possibly related device; resolved without sequelae.Rectal bleeding: grade 3; serious - led to hospitalisation; anticipated; possibly related device; resolved without sequelae.No device malfunction was reported and no corrective and preventive action (capa) plan has been identified.The lot number associated with the therasphere administration was not reported, therefore no investigation could be performed.If additional information becomes available, a follow up report will be submitted.No other information is available that could confirm/deny the alleged event.At this time this report is considered final.
 
Event Description
Auto-notification received from (b)(6) 19-mar-2020 for this patient enrolled on the (b)(6) study.Therasphere treatment date: (b)(6) 2019.Total administered: 0.77 gbq via femoral artery.Volume of total perfused liver 282 cm^3.Sae start date: (b)(6) 2019.Gi hemorrhage and rectal bleeding required hospitalization (b)(6) 2019.Discharge date: (b)(6) 2019.Outcome: resolved.Reported as possibly related to therasphere device and administration procedure.Other causality: concurrent disease (digestive hemorrhages on varicose veins).Patient received one administration of therasphere® on (b)(6) 2019, 0.77 gbq in the left femoral artery.On (b)(6) 2019, the patient was hospitalised with melena and rectal bleeding (4 times of abundant rectal bleeding without clots).This led to a serious deterioration in health and required in-patient hospitalisation or prolongation of existing hospitalisation.On the (b)(6) 2019, epigastric pain in the night lasting 4hrs without irradiation.Occurrence of 2 melenas in the morning (lasting 8hrs).At hospital, normal clinical examination, no pain.Improving thrombocytopenia, scanner thorax abdomen and pelvis: no active bleeding, lack of scalability of transjugular intrahepatic portosystemic shunt (tips) level.The patient was discharged on the (b)(6) 2019.The investigator has listed the causality probably related to the administration procedure, to the device and digestive hemorrhages on varicose veins.Action taken: concomitant medication and stop anticoagulation at 2 months of treatment.The reported events are known adverse events listed in the ifu/risk management documentation.The events were not reported to btg/bsc in 2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERASPHERE
Type of Device
YTTRIUM-90 GLASS MICROSPHERES, PRODUCT CODE: NAW
Manufacturer (Section D)
BIOCOMPATIBLES UK LTD
chapman house farnham bus park
weydon lane
farnham, GU9 8 QL
UK  GU9 8QL
Manufacturer (Section G)
BIOCOMPATIBLES UK
chapman house
weydon lane
farnham, surrey
UK  
Manufacturer Contact
sandra bausback-aballo
300 four falls corporate cntr
300 conshohocken state road
west conshohocken, pa 
3311537
MDR Report Key9956481
MDR Text Key198531061
Report Number3002124543-2020-00008
Device Sequence Number1
Product Code NAW
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
H980006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation Physician
Type of Report Initial
Report Date 03/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Catalogue NumberN/A
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/19/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age47 YR
Patient Weight92
-
-